Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080272 | SCV000112167 | benign | not specified | 2013-07-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000080272 | SCV000309673 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000080272 | SCV000519401 | benign | not specified | 2016-03-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001527259 | SCV001738217 | benign | Miyoshi muscular dystrophy 1 | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002055164 | SCV002406114 | benign | Qualitative or quantitative defects of dysferlin | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000080272 | SCV002034260 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000080272 | SCV002034448 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001795102 | SCV002037065 | likely benign | not provided | no assertion criteria provided | clinical testing |